Browse > Article
http://dx.doi.org/10.7778/jpkm.2017.31.2.048

A Comparative Study of Hataedock versus Probiotics on Immunomodulating Effect in Intestinal Mucosa  

Ahn, Sang Hyun (Department of Anatomy, College of Korean Medicine, Semyung University)
Cha, Ho Yeol (Department of Korean Pediatrics, Pusan National University Hospital)
Kim, Ki Bong (Department of Korean Pediatrics, Pusan National University Hospital)
Publication Information
The Journal of Pediatrics of Korean Medicine / v.31, no.2, 2017 , pp. 48-56 More about this Journal
Abstract
Objectives Hataedock is a treatment that dispels toxic heat and meconium which has been accumulated to the fetus from a pregnant mother via orally administering herbal extracts to a newborn baby. This study was conducted to compare the efficacy of Hataedock, with using the extract of Coptis japonica & Glycyrrhiza uralensis, to the early administration of probiotics for immunomodulation in the intestinal mucosa. Methods NC/Nga mice were divided into three groups; Control group (no treatment), CGT group (3-week-old mice given the extract of Coptis japonica & Glycyrrhiza uralensis), and MBT group (3-week-old mice given a Bifidobacterium). After 2 weeks, the intestinal mucosa tissues of each group of mice were observed. Immunohistochemical staining for IL-4, IL-13, CD40, $Fc{\varepsilon}RI$, $p-I{\kappa}B$, EGF, and VEGF in the intestinal mucosa was performed. Results CGT group showed 65% decrease in IL-4, 67% decrease in IL-13, 58% decrease in CD40, 72% decrease in $Fc{\varepsilon}RI$, 76% decrease in $p-I{\kappa}B$, 41% increase in EGF and 100% increase in VEGF compared to the control group. MBT group also showed 50% decrease in IL-4, 63% decrease in IL-13, 33% decrease in CD40, 53% decrease in $Fc{\varepsilon}RI$, 46% decrease in $p-I{\kappa}B$, 23% increase in EGF and 151% increase in VEGF compared to the control group. Conclusions These results suggest that both Hataedock, with using the extract of Coptis japonica & Glycyrrhiza uralensis, and early administration of probiotics were effective in regulating Th2, relieving inflammation and developing intestinal mucosal tissues. Hataedock with extract of Coptis japonica & Glycyrrhiza uralensis may be more effective for immunomodulation in intestinal mucosa than probiotics.
Keywords
Hataedock; Intestine; Probiotics; Th2 skewed condition; Inflammation;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, Williams H; ISAAC phase three study group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733-43.   DOI
2 Yi YJ, Kim JS. Factors affecting asthma and atopic dermatitis in Korean children: a population-based cross-sectional survey. Child Health Nurs Res. 2015; 21(1):20-7.   DOI
3 Yoo KH. Clinical year in review of asthma for pulmonary physicians: the epidemiologic hypothesis for the relationship between asthma and infectious disease. Tuberc Respir Dis. 2008;65(1):1-6.   DOI
4 Michail S. The role of probiotics in allergic diseases. Allergy Asthma Clin Immunol. 2009;5:5.   DOI
5 Kamada N, Seo SU, Chen GY, Gabriel N. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013;13:321-35.   DOI
6 Kim YH, Choi CY, Chun TH. The preventive and therapeutic effects of probiotics in allergic diseases via immune modulation. J Food Hyg Saf. 2016;31(3): 141-52.   DOI
7 Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med. 2005;257(1):78-92.   DOI
8 Hwang JS, Im SH. Probiotics as an immune modulator for allergic disorders. Pediatr Allergy Respir Dis. 2012;22:325-35.   DOI
9 Kang MS, Chang GT, Kim JH. A study on fetal toxicosis removal therapy. J Korean Orient Pediatr. 2003;17(1): 29-51.
10 Heo J. Donguibogam. 2nd ed. Seoul: Namsandang. 2004.
11 Cha HY, Ahn SH, Jeong AR, Cheon JH, Park SY, Kim KB. The effects of Hataedock on 2,4-dinitrofluorobenzene induced atopic dermatitis like skin lesion in NC/Nga mice. J Korean Orient Pediatr. 2015;29(4): 97-107.   DOI
12 Cha HY, Ahn SH, Jeong AR, Cheon JH, Park SY, Choi JY, Kim KB. Anti-inflammatory effects of Hataedock extracted from Coptidis rhizoma and Glycyrrhiza uralensis on atopic dermatitis-like skin lesions of NC/Nga mouse. J Int Korean Med. 2015;36(4):486-97.
13 Cha HY, Ahn SH, Cheon JH, Park IS, Kim JT, Kim KB. Hataedock treatment has preventive therapeutic effects in atopic dermatitis-induced NC/Nga mice under high-fat diet conditions. Evid Based Complement Alternat Med. 2016;2016:1739760.
14 Ozdemir O. Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. J Clin Exp Immunol. 2010;160(3):295-304.   DOI
15 Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut. 2005;54(3):317-20.   DOI
16 Faria AM, Weiner HL. Oral tolerance. Immunol Rev. 2005;206:232-59.   DOI
17 Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119: 1019-21.   DOI
18 Tang ML, Lahtinen SJ, Boyle RJ. Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr. 2010;22:626-34.
19 Weiner HL. Oral tolerance, an active immunologic process mediated by multiple mechanisms. J Clin Invest. 2000;106:935-7.   DOI
20 Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol. 1994; 6:838-46.   DOI
21 Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8(3):223-46.
22 Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol. 2000;85(1):9-21.   DOI
23 Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS. 1995;103(3):161-79.   DOI
24 Akdis M, Akdis CA. IgE class switching and cellular memory. Nat Immunol. 2012;13(4):312-4.   DOI
25 Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77(4):1033-79.   DOI
26 Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010;125(2Suppl2):S73-80.   DOI
27 Lawrence T. The nuclear factor NF-${\kappa}B$ pathway in inflammation. Cold Spring Harb Perspect Biol. 2009; 1(6):a001651.   DOI
28 Goto Y, Kiyono H. Epithelial barrier: an interface for the cross-communication between gut flora and immune system. Immunol Rev. 2012;245:147-63.   DOI
29 Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci. 2005;30(1):43-52.   DOI
30 Alcamo E, Mizgerd JP, Horwitz BH, Bronson R, Beg AA, Scott M, Doerschuk CM, Hynes RO, Baltimore D. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J Immunol. 2001;167(3):1592-600.   DOI
31 McGhee JR, Fujihashi K. Inside the mucosal immune system. PLoS Biol. 2012;10(9):e1001397.   DOI
32 Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 2003;52(7): 988-97.   DOI
33 Buret A, Gall DG, Olson ME, Hardin JA. The role of epidermal growth factor receptor in microbial infections of the gastrointestinal tract. Microbes Infect. 1999;1:1139-44.   DOI
34 Galan JE, Pace J, Hayman MJ. Involvement of the epidermal growth factor receptor in the invasion of cultured mammalian cells by Salmonella typhimurium. Nature. 1992;357:588-9.   DOI
35 Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 1990;343:82-5.   DOI
36 Resta-Lenert S, Barrett KE. Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2. Gastroenterology. 2002;122:1070-87.   DOI
37 Szabo S, Folkman J, Vattay P, Morales RE, Pinkus GS, Kato K. Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology. 1994;106(4): 1106-11.   DOI
38 Lam EK, Yu L, Wong HP, Wu WK, Shin VY, Tai EK, So WH, Woo PC, Cho CH. Probiotic Lactobacillus rhamnosus GG enhances gastric ulcer healing in rats. Eur J Pharmacol. 2007;565(1-3):171-9.   DOI
39 Dharmani P, De Simone C, Chadee K. The probiotic mixture VSL#3 accelerates gastric ulcer healing by stimulating vascular endothelial growth factor. PLoS one. 2103;8(3):e58671.   DOI